The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Methotrexate Sodium-Global Market Insights and Sales Trends 2025

Methotrexate Sodium-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808068

No of Pages : 99

Synopsis
Methotrexate Sodium drug in this report.
The global Methotrexate Sodium market size is expected to reach US$ 141.7 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Methotrexate Sodium in various end use industries. The expanding demands from the Oral and Injection, are propelling Methotrexate Sodium market. Methotrexate Sodium Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Methotrexate Sodium Solution segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Methotrexate Sodium market, driven by demand from China, the second largest economy with some signs of stabilising, the Methotrexate Sodium market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Methotrexate Sodium, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Methotrexate Sodium market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Methotrexate Sodium market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Methotrexate Sodium sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Methotrexate Sodium covered in this report include Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., Mylan Pharmaceuticals Inc., Teva USA(Barr Laboratories), STADA Pharmaceuticals, Inc and HOSPIRA, etc.
The global Methotrexate Sodium market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qualitest(DAVA Pharmaceuticals)
Roxane Laboratories Inc.
Mylan Pharmaceuticals Inc.
Teva USA(Barr Laboratories)
STADA Pharmaceuticals, Inc
HOSPIRA
Global Methotrexate Sodium market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Methotrexate Sodium market, Segment by Type:
Methotrexate Sodium Tablet
Methotrexate Sodium Solution
Global Methotrexate Sodium market, by Application
Oral
Injection
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Methotrexate Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Methotrexate Sodium Market Overview
1.1 Methotrexate Sodium Product Overview
1.2 Methotrexate Sodium Market Segment by Type
1.2.1 Methotrexate Sodium Tablet
1.2.2 Methotrexate Sodium Solution
1.3 Global Methotrexate Sodium Market Size by Type
1.3.1 Global Methotrexate Sodium Market Size Overview by Type (2018-2029)
1.3.2 Global Methotrexate Sodium Historic Market Size Review by Type (2018-2023)
1.3.3 Global Methotrexate Sodium Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Methotrexate Sodium Sales Breakdown by Type (2018-2023)
1.4.2 Europe Methotrexate Sodium Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Methotrexate Sodium Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Methotrexate Sodium Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Methotrexate Sodium Sales Breakdown by Type (2018-2023)
2 Global Methotrexate Sodium Market Competition by Company
2.1 Global Top Players by Methotrexate Sodium Sales (2018-2023)
2.2 Global Top Players by Methotrexate Sodium Revenue (2018-2023)
2.3 Global Top Players by Methotrexate Sodium Price (2018-2023)
2.4 Global Top Manufacturers Methotrexate Sodium Manufacturing Base Distribution, Sales Area, Product Type
2.5 Methotrexate Sodium Market Competitive Situation and Trends
2.5.1 Methotrexate Sodium Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Methotrexate Sodium Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Methotrexate Sodium as of 2022)
2.7 Date of Key Manufacturers Enter into Methotrexate Sodium Market
2.8 Key Manufacturers Methotrexate Sodium Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Methotrexate Sodium Status and Outlook by Region
3.1 Global Methotrexate Sodium Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Methotrexate Sodium Historic Market Size by Region
3.2.1 Global Methotrexate Sodium Sales in Volume by Region (2018-2023)
3.2.2 Global Methotrexate Sodium Sales in Value by Region (2018-2023)
3.2.3 Global Methotrexate Sodium Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Methotrexate Sodium Forecasted Market Size by Region
3.3.1 Global Methotrexate Sodium Sales in Volume by Region (2024-2029)
3.3.2 Global Methotrexate Sodium Sales in Value by Region (2024-2029)
3.3.3 Global Methotrexate Sodium Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Methotrexate Sodium by Application
4.1 Methotrexate Sodium Market Segment by Application
4.1.1 Oral
4.1.2 Injection
4.2 Global Methotrexate Sodium Market Size by Application
4.2.1 Global Methotrexate Sodium Market Size Overview by Application (2018-2029)
4.2.2 Global Methotrexate Sodium Historic Market Size Review by Application (2018-2023)
4.2.3 Global Methotrexate Sodium Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Methotrexate Sodium Sales Breakdown by Application (2018-2023)
4.3.2 Europe Methotrexate Sodium Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Methotrexate Sodium Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Methotrexate Sodium Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Methotrexate Sodium Sales Breakdown by Application (2018-2023)
5 North America Methotrexate Sodium by Country
5.1 North America Methotrexate Sodium Historic Market Size by Country
5.1.1 North America Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Methotrexate Sodium Sales in Volume by Country (2018-2023)
5.1.3 North America Methotrexate Sodium Sales in Value by Country (2018-2023)
5.2 North America Methotrexate Sodium Forecasted Market Size by Country
5.2.1 North America Methotrexate Sodium Sales in Volume by Country (2024-2029)
5.2.2 North America Methotrexate Sodium Sales in Value by Country (2024-2029)
6 Europe Methotrexate Sodium by Country
6.1 Europe Methotrexate Sodium Historic Market Size by Country
6.1.1 Europe Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Methotrexate Sodium Sales in Volume by Country (2018-2023)
6.1.3 Europe Methotrexate Sodium Sales in Value by Country (2018-2023)
6.2 Europe Methotrexate Sodium Forecasted Market Size by Country
6.2.1 Europe Methotrexate Sodium Sales in Volume by Country (2024-2029)
6.2.2 Europe Methotrexate Sodium Sales in Value by Country (2024-2029)
7 Asia-Pacific Methotrexate Sodium by Region
7.1 Asia-Pacific Methotrexate Sodium Historic Market Size by Region
7.1.1 Asia-Pacific Methotrexate Sodium Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Methotrexate Sodium Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Methotrexate Sodium Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Methotrexate Sodium Forecasted Market Size by Region
7.2.1 Asia-Pacific Methotrexate Sodium Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Methotrexate Sodium Sales in Value by Region (2024-2029)
8 Latin America Methotrexate Sodium by Country
8.1 Latin America Methotrexate Sodium Historic Market Size by Country
8.1.1 Latin America Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Methotrexate Sodium Sales in Volume by Country (2018-2023)
8.1.3 Latin America Methotrexate Sodium Sales in Value by Country (2018-2023)
8.2 Latin America Methotrexate Sodium Forecasted Market Size by Country
8.2.1 Latin America Methotrexate Sodium Sales in Volume by Country (2024-2029)
8.2.2 Latin America Methotrexate Sodium Sales in Value by Country (2024-2029)
9 Middle East and Africa Methotrexate Sodium by Country
9.1 Middle East and Africa Methotrexate Sodium Historic Market Size by Country
9.1.1 Middle East and Africa Methotrexate Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Methotrexate Sodium Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Methotrexate Sodium Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Methotrexate Sodium Forecasted Market Size by Country
9.2.1 Middle East and Africa Methotrexate Sodium Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Methotrexate Sodium Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Qualitest(DAVA Pharmaceuticals)
10.1.1 Qualitest(DAVA Pharmaceuticals) Company Information
10.1.2 Qualitest(DAVA Pharmaceuticals) Introduction and Business Overview
10.1.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Products Offered
10.1.5 Qualitest(DAVA Pharmaceuticals) Recent Development
10.2 Roxane Laboratories Inc.
10.2.1 Roxane Laboratories Inc. Company Information
10.2.2 Roxane Laboratories Inc. Introduction and Business Overview
10.2.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Roxane Laboratories Inc. Methotrexate Sodium Products Offered
10.2.5 Roxane Laboratories Inc. Recent Development
10.3 Mylan Pharmaceuticals Inc.
10.3.1 Mylan Pharmaceuticals Inc. Company Information
10.3.2 Mylan Pharmaceuticals Inc. Introduction and Business Overview
10.3.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Products Offered
10.3.5 Mylan Pharmaceuticals Inc. Recent Development
10.4 Teva USA(Barr Laboratories)
10.4.1 Teva USA(Barr Laboratories) Company Information
10.4.2 Teva USA(Barr Laboratories) Introduction and Business Overview
10.4.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva USA(Barr Laboratories) Methotrexate Sodium Products Offered
10.4.5 Teva USA(Barr Laboratories) Recent Development
10.5 STADA Pharmaceuticals, Inc
10.5.1 STADA Pharmaceuticals, Inc Company Information
10.5.2 STADA Pharmaceuticals, Inc Introduction and Business Overview
10.5.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.5.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Products Offered
10.5.5 STADA Pharmaceuticals, Inc Recent Development
10.6 HOSPIRA
10.6.1 HOSPIRA Company Information
10.6.2 HOSPIRA Introduction and Business Overview
10.6.3 HOSPIRA Methotrexate Sodium Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HOSPIRA Methotrexate Sodium Products Offered
10.6.5 HOSPIRA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Methotrexate Sodium Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Methotrexate Sodium Industrial Chain Analysis
11.4 Methotrexate Sodium Market Dynamics
11.4.1 Methotrexate Sodium Industry Trends
11.4.2 Methotrexate Sodium Market Drivers
11.4.3 Methotrexate Sodium Market Challenges
11.4.4 Methotrexate Sodium Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Methotrexate Sodium Distributors
12.3 Methotrexate Sodium Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’